News Analysis: New F.D.A.: Transparence and Flexibility
Friday, September 24, 2010 - 22:21
in Psychology & Sociology
In its decision on the diabetes drug Avandia, the agency has shown a shift from keeping a united front and dependence on clinical, rather than academic, trials.